CN100387703C - 多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 - Google Patents
多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 Download PDFInfo
- Publication number
- CN100387703C CN100387703C CNB031270700A CN03127070A CN100387703C CN 100387703 C CN100387703 C CN 100387703C CN B031270700 A CNB031270700 A CN B031270700A CN 03127070 A CN03127070 A CN 03127070A CN 100387703 C CN100387703 C CN 100387703C
- Authority
- CN
- China
- Prior art keywords
- phospho
- fatly
- umbrella
- polysaccharide
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000012258 culturing Methods 0.000 title claims abstract 4
- -1 phospho Chemical class 0.000 title claims description 131
- 230000001580 bacterial effect Effects 0.000 title claims description 35
- 150000004676 glycans Chemical class 0.000 claims abstract description 53
- 239000005017 polysaccharide Substances 0.000 claims abstract description 53
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 53
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 230000036592 analgesia Effects 0.000 claims abstract description 3
- 241000894006 Bacteria Species 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 238000001556 precipitation Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 230000003053 immunization Effects 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 235000015099 wheat brans Nutrition 0.000 claims description 6
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 5
- 235000007466 Corylus avellana Nutrition 0.000 claims description 5
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 5
- 229960004756 ethanol Drugs 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 5
- 239000004571 lime Substances 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 229910052602 gypsum Inorganic materials 0.000 claims description 4
- 239000010440 gypsum Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 3
- 239000011121 hardwood Substances 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 230000003544 deproteinization Effects 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000011218 seed culture Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 241000722337 Pholiota Species 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 abstract description 34
- 108020004707 nucleic acids Proteins 0.000 abstract description 34
- 150000007523 nucleic acids Chemical class 0.000 abstract description 34
- 241000722336 Pholiota aurivella Species 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000002503 metabolic effect Effects 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 64
- 230000000694 effects Effects 0.000 description 30
- 239000000306 component Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 241000699670 Mus sp. Species 0.000 description 16
- 230000012010 growth Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 210000001541 thymus gland Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 10
- 230000000242 pagocytic effect Effects 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000036737 immune function Effects 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 240000002853 Nelumbo nucifera Species 0.000 description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000000050 nutritive effect Effects 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 230000002929 anti-fatigue Effects 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 238000001243 protein synthesis Methods 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 241000228232 Aspergillus tubingensis Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 240000007582 Corylus avellana Species 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- 230000000146 antalgic effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 4
- 230000002949 hemolytic effect Effects 0.000 description 4
- 230000007954 hypoxia Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000012533 medium component Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004614 tumor growth Effects 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002992 thymic effect Effects 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- 241000222485 Agaricales Species 0.000 description 1
- 241000222382 Agaricomycotina Species 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 241001481296 Malus spectabilis Species 0.000 description 1
- 101100281510 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) met-6 gene Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000958510 Stropharia rugosoannulata Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 210000000026 apposition eye Anatomy 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 剂量(mg/kg·d) | 动物数(只) | 脾指数 | 比率<sup>#</sup>(%) | 胸腺指数 | 比率<sup>##</sup>(%) |
正常组 | - | 12 | 6.76±0.58 | 2.32±0.43 | ||
对照 | - | 18 | 13.39±0.45 | 198.1 | 1.31±0.57 | 56.5 |
多脂磷伞多糖 | 1000 | 12 | 8.63±0.62<sup>*</sup> | 127.8 | 1.70±0.95 | 73.3 |
500 | 12 | 9.86±0.52 | 145.9 | 1.92±0.24<sup>□*</sup> | 78.6 | |
250 | 12 | 10.23±1.36 | 151.3 | 1.55±0.37 | 66.8 | |
环磷酰胺 | 0.01 | 12 | 9.32±0.87 | 137.9 | 1.61±0.69 | 69.4 |
菌株 株数 | MIC |
金黄色葡萄球菌 2 | 9.75 |
大肠杆菌 2 | 4.875 |
志贺痢疾杆菌 2 | >78 |
白色念珠菌 2 | >78 |
杂曲霉菌 2 | >78 |
组别 | 小鼠(只) | 吞噬率(%) | P值 |
蒸馏水组 | 10 | 21.875±5.60 | |
低剂量组 | 10 | 34.98±10.12<sup>*</sup> | <0.05 |
中剂量组 | 10 | 39.94±9.06<sup>*</sup> | <0.05 |
高剂量组 | 10 | 44.11±18.56<sup>**</sup> | <0.01 |
组别 | 小鼠(只) | HC<sub>50</sub> | P值 |
蒸馏水组 | 10 | 270.93±28.09 | |
低剂量组 | 10 | 275.52±21.54 | >0.05 |
中剂量组 | 10 | 275.81±23.59 | >0.05 |
高剂量组 | 10 | 281.08±13.91 | <0.05 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031270700A CN100387703C (zh) | 2003-06-11 | 2003-06-11 | 多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031270700A CN100387703C (zh) | 2003-06-11 | 2003-06-11 | 多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1513973A CN1513973A (zh) | 2004-07-21 |
CN100387703C true CN100387703C (zh) | 2008-05-14 |
Family
ID=34239679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031270700A Expired - Fee Related CN100387703C (zh) | 2003-06-11 | 2003-06-11 | 多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100387703C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110903989A (zh) * | 2019-12-21 | 2020-03-24 | 通化兴华药业有限责任公司 | 安络小皮伞Mar-1菌株、以该菌种人工培育安络小皮伞固体菌丝体的方法及其药物用途 |
CN113637594B (zh) * | 2021-10-18 | 2022-01-07 | 山东蓬勃生物科技有限公司 | 一种多脂鳞伞菌株yx1、培养方法及其应用 |
CN116462537A (zh) * | 2023-04-17 | 2023-07-21 | 漳州环境集团有限公司 | 一种绿化垃圾回收方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301774A (zh) * | 1999-12-24 | 2001-07-04 | 中国科学院上海药物研究所 | 夹竹桃花多糖及其衍生物、制备方法及其应用 |
-
2003
- 2003-06-11 CN CNB031270700A patent/CN100387703C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301774A (zh) * | 1999-12-24 | 2001-07-04 | 中国科学院上海药物研究所 | 夹竹桃花多糖及其衍生物、制备方法及其应用 |
Non-Patent Citations (8)
Title |
---|
滑菇多糖的制备工艺. 宋玉光,李庆章,高学军.中国生化药物杂志,第23卷第4期. 2002 |
滑菇多糖的制备工艺. 宋玉光等.中国生化药物杂志,第23卷第4期. 2002 |
滑菇多糖的制备工艺. 宋玉光,李庆章,高学军.中国生化药物杂志,第23卷第4期. 2002 * |
滑菇多糖的制备工艺. 宋玉光等.中国生化药物杂志,第23卷第4期. 2002 * |
黄伞的生物学特性及人工驯化栽培技术. 张剑斌,徐连峰,董希文,严枫,张福平,华淑丽.防护林科技,第4期. 2000 |
黄伞的生物学特性及人工驯化栽培技术. 张剑斌.防护林科技,第4期. 2000 |
黄伞的生物学特性及人工驯化栽培技术. 张剑斌,徐连峰,董希文,严枫,张福平,华淑丽.防护林科技,第4期. 2000 * |
黄伞的生物学特性及人工驯化栽培技术. 张剑斌.防护林科技,第4期. 2000 * |
Also Published As
Publication number | Publication date |
---|---|
CN1513973A (zh) | 2004-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102671009B (zh) | 植物发酵提取物及其粉末以及其组合物的制造方法 | |
CN102894207B (zh) | 一种提高机体免疫力复合中草药猪饲料添加剂及制备方法 | |
CN101623098B (zh) | 一种含有发酵虫草和灵芝的保健食品及其制备方法 | |
CN102242044B (zh) | 一种蝉花酒及其制备 | |
CN104522313B (zh) | 虫草属菌种发酵物在降低牛乳体细胞数量中的应用 | |
CN102047814A (zh) | 一种微通气椴木栽培樟芝的方法 | |
CN102875225A (zh) | 桑黄菌株液体发酵培养基和发酵产桑黄多糖的方法 | |
CN102552335B (zh) | 一种中药保健品及其制备方法和应用 | |
CN108144040A (zh) | 补肾生精的虫草牡蛎肽复合物 | |
CN101463326A (zh) | 广东虫草菌丝体的生产方法 | |
CN102613331B (zh) | 蜜环菌发酵茶、蜜环菌发酵茶组合物及其制备及方法 | |
CN103285043B (zh) | 具有抗肿瘤功效的食用真菌蛋白质提取物的制备方法 | |
CN102224922B (zh) | 一种具有免疫调节及改善肠胃道功能的保健食品 | |
CN104254594A (zh) | 添加硒原液可排出放射性锶的功能性马格利酒及其制造方法 | |
CN109439719A (zh) | 一种基于杜仲的真菌双向固体发酵技术及其应用 | |
CN100387703C (zh) | 多脂磷伞Pa-I·H菌株及培育多脂磷伞的方法和以其活性成分制成的药物 | |
CN107223966A (zh) | 一种用于提高免疫力的蓉草甘口服液及其制备方法 | |
CN111700142A (zh) | 一种发酵茯苓酸代用茶的制备方法 | |
CN106074799A (zh) | 一种新会柑食用菌酵素的生产方法 | |
CN105754865B (zh) | 利用诱变菌株生产灵芝菌丝体原料的方法 | |
CN105586266B (zh) | 一种生产富硒冬虫夏草菌丝原料的方法 | |
CN103392513A (zh) | 冬虫夏草菌丝体发酵物及其应用 | |
CN1274751A (zh) | 九州虫草菌的人工培养方法及其子实体的应用 | |
CN105754866B (zh) | 一株生产灰树花菌丝体的灰树花诱变菌株 | |
CN109832085A (zh) | 双孢虫草及其人工栽培方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI HI-TECH UNITED BIOTECHNOLOGY R & D LTD. Free format text: FORMER OWNER: CHINA GAOKE GROUP CO., LTD. Effective date: 20050304 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050304 Address after: No. 501, Jingang Road, No. 3, block B, Pudong, Shanghai Applicant after: Shanghai Gaoke Union Biotechnology Development Co., Ltd. Address before: South 17 floor, China Merchants Plaza, 333 North Chengdu Road, Shanghai Applicant before: China Gaoke Group Corp., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080514 Termination date: 20180611 |